OPHTHALMIC DRUG DELIVERY SYSTEM: AN OVERVIEW

Authors

  • Vimal Kumar Shahwal TIT College of pharmacy,Bhopal (M.P.).
  • B. K. Dubey TIT College of pharmacy,Bhopal (M.P.).
  • Mithun Bhoumick TIT College of pharmacy,Bhopal (M.P.).
  • Abhay Upadhyay College of pharmacy IPS Academy, Indore M.P.

DOI:

https://doi.org/10.7439/ijbr.v2i6.119

Keywords:

Hypocellular bone marrow. Aplastic amemia, pancytopenia, immunosuppressive therapy

Abstract

Ideal ophthalmic drug delivery must be able to sustain the drug release and to remain in the vicinity of front of the eye for prolong period of time. Ocular drug delivery is one of the interesting and challenging endeavors facing the pharmaceutical scientist. As an isolated organ the eye is very difficult to study from a drug delivery point of view. Eye drops and eye ointments are conventional ocular dosage forms. They have certain disadvantages like frequent administration, poor availability, massive and unpredictable doses, and drainage of medication by tear and nasolacrimal fluid. Most of ophthalmic drugs are administered topically in the form of eye drops, a dosage form consisting of buffered, isotonic, aqueous solution or suspensions of the drug. Ophthalmic CDDS (controlled drug delivery system) have been mainly prepared as gels, ointments, liposomes, micro and Nanoparticles, microspheres and ocular minitablets (MT) or films or inserts.

Downloads

Download data is not yet available.

Downloads

Published

2011-07-01

Issue

Vol. 2 No. 6 (2011): Jun

Section

Review Article

License

Copyright (c) 2011 International Journal of Biomedical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
  • An author must submit Copyright form After acceptance of the article.

How to Cite

1.
OPHTHALMIC DRUG DELIVERY SYSTEM: AN OVERVIEW. Int Jour of Biomed Res [Internet]. 2011 Jul. 1 [cited 2026 Mar. 10];2(6):391-410. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/667